Recall: aripiprazole 1mg/ml oral solution
Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution (EL (19)A/20)
Accord-UK Ltd is recalling these batches due to the potential for small particles of aripiprazole active material to be present, which may affect the efficacy of the product. No relevant product complaints or adverse reaction reports have been received by the company from the UK market to date.
Click here for more information.
Learn how to help customers ease the discomfort of haemorrhoids with suitable recommendations and self-care advice
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.